Antonio Marzio
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
-
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- DNA Repair Mechanisms
Papers in
- Oncology 6
- PARP inhibition in cancer therapy 2
-
- Ubiquitin and proteasome pathways 6
- DNA Repair Mechanisms 3
- Photosynthetic Processes and Mechanisms 2
- RNA modifications and cancer 2
- Co-authors
- Michele Pagano (10 shared papers)Bryan S. Matsuura (1 shared paper)Martin Reynders (1 shared paper)Marleen Bérouti (1 shared paper)Daniele Simoneschi (1 shared paper)Dirk H. Trauner (1 shared paper)Chiara Merigliano (2 shared papers)Maurizio Gatti (2 shared papers)
- Journals
- Molecular Cell (3 papers)Cell Death and Differentiation (1 paper)Nature Communications (1 paper)Nature Cancer (1 paper)Science Advances (1 paper)
- Partner nations
- United StatesItalyIsrael
In The Last Decade
Antonio Marzio
16 papers receiving 993 citations
Peers
Comparison fields: 5 of 71
- Oncology 297
- Molecular Biology 704
- Cell Biology 140
- Hematology 60
- Cancer Research 57
Countries citing papers authored by Antonio Marzio
This map shows the geographic impact of Antonio Marzio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Marzio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Marzio more than expected).
Fields of papers citing papers by Antonio Marzio
This network shows the impact of papers produced by Antonio Marzio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Marzio. The network helps show where Antonio Marzio may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonio Marzio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 259 | |
| 2 | 2021 | 112 | |
| 3 | 2019 | 87 | |
| 4 | 2019 | 86 | |
| 5 | 2021 | 86 | |
| 6 | 2015 | 68 | |
| 7 | 2014 | 67 | |
| 8 | 2018 | 63 | |
| 9 | 2023 | 55 | |
| 10 | 2014 | 43 | |
| 11 | 2017 | 31 | |
| 12 | 2016 | 23 | |
| 13 | 2024 | 16 | |
| 14 | 2024 | 8 | |
| 15 | 2024 | 8 | |
| 16 | 2020 | 1 |
About Antonio Marzio
Antonio Marzio is a scholar working on Oncology, Molecular Biology, Cell Biology, Immunology and Epidemiology, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), DNA Repair Mechanisms (3 papers), Microtubule and mitosis dynamics (2 papers), PARP inhibition in cancer therapy (2 papers), Autophagy in Disease and Therapy (2 papers), Photosynthetic Processes and Mechanisms (2 papers), RNA modifications and cancer (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Oncology (297 citations), Molecular Biology (704 citations), Cell Biology (140 citations), Hematology (60 citations) and Cancer Research (57 citations). Antonio Marzio has collaborated with scholars based in United States, Italy and Israel. Frequent co-authors include Michele Pagano, Bryan S. Matsuura, Martin Reynders, Marleen Bérouti, Daniele Simoneschi, Dirk H. Trauner, Chiara Merigliano, Maurizio Gatti, Fiammetta Vernı̀ and Joseph Puccini. Their work appears in journals such as Molecular Cell, Cell Death and Differentiation, Nature Communications, Nature Cancer and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.